The FDA increased pressure on sponsors to report clinical trial results, sending reminders to more than 2,200 sponsors and researchers tied to over 3,000 clinical trials. The agency said it found that about 30% of registered studies were not up to date with results disclosures on clinicaltrials.gov. This action follows the FDA’s broader push to improve trial transparency and reduce gaps between study execution and public reporting. By emphasizing delinquency across both drug and device research stakeholders, the regulator signaled that incomplete reporting remains an enforcement priority. Sponsors facing reporting gaps may now need to update timelines for results posting, especially for multi-site trials and those with complex datasets.